½ÃÀ庸°í¼­
»óǰÄÚµå
1423586

¸¶ÀÌÅ©·Î¼­Àú¸® ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç° À¯Çü, ½Ã¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ªº° ¼¼°è ºÐ¼®

Microsurgery Market Forecasts to 2030 - Global Analysis By Product Type (Operating Microscopes, Microsurgery Needle Holder, Micro Forceps, Micro Sutures and Other Product Types), Procedure, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ¼¼°è ¸¶ÀÌÅ©·Î¼­Àú¸® ½ÃÀåÀº 2023³â 22¾ï 4,000¸¸ ´Þ·¯ ±Ô¸ðÀ̸ç, ¿¹Ãø ±â°£ µ¿¾È ¿¬Æò±Õ 7.2% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 36¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸¶ÀÌÅ©·Î¼­Àú¸®´Â ¼¶¼¼ÇÑ ºÀÇÕ»ç, Çö¹Ì°æ°ú °°Àº È®´ë ÀåÄ¡, Á¤¹ÐÇÑ ±â±¸¸¦ »ç¿ëÇÏ¿© ±ØÈ÷ ÀÛÀº ½Åü ºÎÀ§¸¦ ¼ö¼úÇÏ´Â °íµµ·Î Àü¹®È­µÈ ¼ö¼úÀÔ´Ï´Ù. ¿Ü°úÀÇ»ç´Â ±úÁö±â ½¬¿î Á¶Á÷, Ç÷°ü, ½Å°æ µî ¶§·Î´Â À°¾ÈÀ¸·Î º¼ ¼ö ¾ø´Â ¹Ì¼¼ÇÑ ÇØºÎÇÐÀû Ư¡¿¡ ´ëÇØ º¹ÀâÇÑ ¼ö¼úÀ» Çϱ⵵ ÇÕ´Ï´Ù. ¶ÇÇÑ, ¸¶ÀÌÅ©·Î¼­Àú¸® ±â¼úÀÇ Á¤¹Ð¼º ¶§¹®¿¡ À̸¦ ¼öÇàÇÏ´Â ¿Ü°úÀÇ»ç´Â Ưº°ÇÑ ÈÆ·Ã°ú ´É·ÂÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù. ±× ±â¼úÀº ±Ø¼¼ ¹Ù´Ã°ú ºÀÇջ縦 ÀÌ¿ëÇÑ Á¤¹ÐÇÑ ºÀÇÕ, ¼¼½ÉÇÑ ¹è·Á, ¼¶¼¼ÇÑ Á¶Á÷ Á¶ÀÛ µîÀÔ´Ï´Ù.

±¹¸³ÀÇÇеµ¼­°üÀÌ 2021³â 6¿ù¿¡ ¹ßÇ¥ÇÑ Á¶»ç °á°ú¿¡ µû¸£¸é, È®´ë°æÀ¸·Î Ä¡±Ù¸éÀ» µ¤´Â ¸¶ÀÌÅ©·Î¼­Àú¸®¹ýÀÌ ±âÁ¸ ¸¶ÀÌÅ©·Î¼­Àú¸®¹ýº¸´Ù Ä¡ÀºÀÇ µÎ²²¿Í ȯÀÚ ¸¸Á·µµ°¡ Çâ»óµÇ¾ú°í, ¸¶ÀÌÅ©·Î¼­Àú¸® ºÎÀ§ÀÇ ½Å»ýÇ÷°üÀÌ ´õ »¡¸® Ä¡À¯µÇ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ´õ »¡¸® Ä¡À¯µÇ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

¸¸¼ºÁúȯÀÇ Áõ°¡

½ÉÇ÷°ü Áúȯ, ´ç´¢º´, ¾Ï, ½Å°æ Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀº Á¾Á¾ º¹ÀâÇϰí Á¤¹ÐÇÑ ¿Ü°úÀû °³ÀÔÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Áúº´À» Ä¡·áÇÏ´Â µ¥ ÀÖ¾î ¸¶ÀÌÅ©·Î¼­Àú¸®´Â Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¸¶ÀÌÅ©·Î¼­Àú¸® ±â¼ú°ú ±â±â·Î ÃËÁøµÇ´Â ÃÖ¼Òħ½À ¼ö¼úÀº ¿Ü»ó °¨¼Ò, ȸº¹ ½Ã°£ ´ÜÃà, ȯÀÚ ¿¹ÈÄ °³¼±À» °¡Á®¿É´Ï´Ù. ¸¶ÀÌÅ©·Î¼­Àú¸® ½ÃÀåÀº ȯÀÚ¿Í ¿Ü°úÀÇ»çµé »çÀÌ¿¡¼­ ´ú ħ½ÀÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ¼±È£ÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Ãß¼¼ÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù.

»õ·Î¿î ¸¶ÀÌÅ©·Î¼­Àú¸® ±â¼úÀ» ±âÁ¸ ÀÇ·á½Ã½ºÅÛ¿¡ ÅëÇÕ

»õ·Î¿î ¸¶ÀÌÅ©·Î¼­Àú¸® ±â¼úÀ» ±âÁ¸ ÀÇ·á ½Ã½ºÅÛ¿¡ ÅëÇÕÇÏ·Á¸é »ó´çÇÑ °èȹ°ú ½ÇÇàÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¼ö¼ú½Ç, ÀüÀÚ ÀÇ·á ±â·Ï(EHR) ½Ã½ºÅÛ, ±âŸ ¼ö¼ú Àåºñ µî ÇöÀçÀÇ ÀÎÇÁ¶ó¿Í ÀÌ·¯ÇÑ ±â¼úÀ» ÅëÇÕÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ º¹À⼺Àº µµÀÔ ´Ü°èÀÇ Áö¿¬°ú Ãß°¡ ºñ¿ë ¹ß»ýÀ¸·Î À̾îÁý´Ï´Ù. ¶ÇÇÑ, ¼­·Î ´Ù¸¥ ±â¼ú ¹× ¼ÒÇÁÆ®¿þ¾î Ç÷§Æû °£ÀÇ È£È¯¼º ¹®Á¦°¡ ¹ß»ýÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ºñÈ¿À²¼º°ú µ¥ÀÌÅÍ °ü¸® ¹®Á¦·Î À̾îÁ® ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¿Ü°ú ¼ö¼úÀÇ ±â¼ú ¹ßÀüÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù

±â¼úÀÇ ¹ßÀüÀº ƯÈ÷ ¼ö¼ú¿ë Çö¹Ì°æ, ¿µ»ó ÃÔ¿µ ¹æ½Ä ¹× ±â±¸¿Í °ü·ÃÇÏ¿© ¹Ì¼¼ ¼ö¼ú Áß Á¤È®¼º°ú °¡½Ã¼ºÀ» Å©°Ô Çâ»ó½ÃÄ×½À´Ï´Ù. Àç·á °úÇÐ ºÐ¾ßÀÇ ²÷ÀÓ¾ø´Â °³¹ßÀº ¼ö¼ú °á°ú¸¦ Çâ»ó½ÃŰ´Â ƯÁ¤ ±â±¸¿Í Àç·á¸¦ ¸¸µé¾î³»°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ÃֽŠÇÕ±Ý ¹× º¹ÇÕÀç·á·Î ±¸¼ºµÈ ¹Ì¼¼ ¼ö¼ú±â±¸´Â »ýü ÀûÇÕ¼º, ³»±¸¼º ¹× Á¤¹Ðµµ°¡ Çâ»óµÇ¾î Ä¡·á Áß È¿°ú¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

³ôÀº ºñ¿ë

Ư¼öÇÑ ¸¶ÀÌÅ©·Î¼­Àú¸® Àåºñ, ±â±¸, ÈÆ·Ã°ú °ü·ÃµÈ ¸·´ëÇÑ ºñ¿ëÀ¸·Î ÀÎÇØ ¸¶ÀÌÅ©·Î¼­Àú¸®¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ Áö¿ªÀ̳ª °³¹ßµµ»ó±¹ µî ¼Ò±Ô¸ð ÀÇ·á½Ã¼³Àº Ãʱâ ÅõÀÚ ¹× Áö¼ÓÀûÀÎ ºñ¿ë Á¶´Þ¿¡ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Áö¿ª¿¡¼­´Â ¸¶ÀÌÅ©·Î¼­Àú¸® ¼­ºñ½º ÀÌ¿ëÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÎ´ãÀº ¸¶ÀÌÅ©·Î¼­Àú¸® ºÎ¹®ÀÇ ¹ßÀü°ú ÷´Ü ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¸¦ À§ÇÑ ÀÚ±Ý ¹èºÐÀ» Á¦ÇÑÇϰí Àü¹ÝÀûÀÎ ÀÇ·á ¼­ºñ½ºÀÇ Áú¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ ´ëÀ¯ÇàÀº ¸¶ÀÌÅ©·Î¼­Àú¸® ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÄ ´Ù¾çÇÑ Ãø¸é¿¡¼­ È¥¶õÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ÀÇ·á ±â°üÀÌ Àü¿°º´ ´ëÀÀ¿¡ ÀÚ¿øÀ» ¿ì¼±¼øÀ§¸¦ µÎ¸é¼­ ¼±ÅÃÀû ¸¶ÀÌÅ©·Î¼­Àú¸® ¼ö¼úÀÌ Å©°Ô °¨¼ÒÇÏ¿© ¼ö¼úÀÌ ¿¬±âµÇ°í ȯÀÚ ¼ö°¡ °¨¼ÒÇß½À´Ï´Ù. °ø±Þ¸ÁÀÇ È¥¶õÀº Á¦Á¶»óÀÇ Á¦¾à°ú ¹°·ù ¹®Á¦·Î ÀÎÇØ Ư¼ö ¸¶ÀÌÅ©·Î¼­Àú¸®±â±¸¿Í ¼ö¼ú¿ë Çö¹Ì°æÀÇ °¡¿ë¼º¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¼ö¼ú Áß ¾ö°ÝÇÑ ¾ÈÀü ÇÁ·ÎÅäÄݰú °³Àκ¸È£±¸(PPE)ÀÇ »ç¿ëÀÌ Àǹ«È­µÇ¾î ÀýÂ÷ÀÇ ¿öÅ©Ç÷ο쿡 ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¼ö¼ú¿ë Çö¹Ì°æ ºÐ¾ß°¡ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»ó

¸¶ÀÌÅ©·Î¼­Àú¸®¿¡ »ç¿ëµÇ´Â ¼ö¼ú¿ë Çö¹Ì°æÀº ±¤ÇÐ ½Ã½ºÅÛ, °íÇØ»óµµ Ä«¸Þ¶ó, Á¶¸í ½Ã½ºÅÛ µîÀÇ Æ¯Â¡À¸·Î ÀÎÇØ È®´ë ¹× ½Ã¾ß È®´ë°¡ °¡´ÉÇϱ⠶§¹®¿¡ À¯¸®ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Çö¹Ì°æÀº Àǻ翡°Ô ¼ö¼ú ºÎÀ§¸¦ ¼±¸íÇÏ°í ¿Ïº®ÇÏ°Ô º¼ ¼ö ÀÖ¾î Á¤È®Çϰí ü°èÀûÀÎ ¼ö¼úÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ Çö¹Ì°æÀº ºÎÀΰú, ºñ´¢±â°ú, ½Å°æ°ú, ¾È°ú, ¼ºÇü¿Ü°ú, Á¤Çü¿Ü°ú, À̺ñÀÎÈİú µî ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ½ÃÀå È®´ë¸¦ ÃËÁøÇÕ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â ½Å°æÇÐÀû ¸¶ÀÌÅ©·Î¼­Àú¸® ºÎ¹®ÀÔ´Ï´Ù.

½Å°æ ¸¶ÀÌÅ©·Î¼­Àú¸® ºÐ¾ß´Â ³ú, ô¼ö, ½Å°æ ¹× ÁÖº¯ Á¶Á÷¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ´Ù¾çÇÑ ¼ö¼úÀÌ ½Å°æ ¸¶ÀÌÅ©·Î¼­Àú¸® ºÐ¾ß¿¡ Æ÷ÇԵDZ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼ú¿¡¼­´Â ÀÛÀº ½Å°æ ±¸Á¶¹°À» º¸°í ÀÛ¾÷Çϱâ À§ÇØ Ã·´Ü ±¤ÇÐ, °í¹èÀ² ¹× Á¶¸í ±â´ÉÀ» °®Ãá °íǰÁú ¼ö¼ú¿ë Çö¹Ì°æÀÌ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Çö¹Ì°æÀº ½Å°æ¿Ü°ú ÀÇ»çÀÇ ½Ã·ÂÀ» Çâ»ó½ÃÄÑ º¹ÀâÇÑ ¼ö¼úÀ» Á¤È®ÇÏ°Ô ¼öÇàÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

ºÏ¹Ì Áö¿ªÀº °íµµ·Î ¹ß´ÞµÈ ÀÇ·á ½Ã½ºÅÛ, ³ôÀº °¨¿° ¹ß»ý·ü, ´Ù¼öÀÇ ´ë±Ô¸ð ±¹¸³ ÀÓ»ó ¿¬±¸¼Ò, ÷´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼º µîÀÇ ÀÌÀ¯·Î ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ȯÀÚÃþ È®´ë¿¡ µû¸¥ °¨¿° Áø´Ü ŰƮ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿Ü°ú ÀÇ»çÀÇ ¼ö¼ú¿ë Çö¹Ì°æ »ç¿ë¿¡ ´ëÇÑ »çȸÀû ÀÎ½Ä Áõ°¡ ¹× ±ÔÁ¦ ±â°üÀÇ ½ÂÀεµ ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÏ´Â ¿äÀÎÀÔ´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ CAGRÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¸¸¼º Áúȯ°ú °ü·ÃµÈ ¹®Á¦¸¦ °ÞÀ» °¡´É¼ºÀÌ ³ôÀº ³ëÀÎ Àα¸ÀÇ Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù. ¾÷°è ¼±µÎ ¾÷üÀÇ ±â¼ú Çõ½ÅÀÌ ºÎÁ·ÇÏ¿© µ¶¸³ÀûÀÎ ½Å±Ô »ç¾÷ÀÚ°¡ ½ÃÀå¿¡ ÁøÀÔÇÏ¿© °íǰÁúÀÇ ÇÕ¸®ÀûÀÎ °¡°ÝÀÇ Á¦Ç°À» Á¦°øÇϰí ÀÖÀ¸¸ç, °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù:

  • ȸ»ç ÇÁ·ÎÇÊ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®(ÃÖ´ë 3°³»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤Ä¡, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º °ËÅä¿¡ µû¸¥)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù¹ý
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¼­Àú¸® ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¼ö¼ú¿ë Çö¹Ì°æ
  • ¸¶ÀÌÅ©·Î¼­Àú¸® ¹Ù´Ã Ȧ´õ
  • ¸¶ÀÌÅ©·Î °âÀÚ
  • ¸¶ÀÌÅ©·Î ºÀÇÕ»ç
  • ±âŸ Á¦Ç° À¯Çü

Á¦6Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¼­Àú¸® ½ÃÀå : ½Ã¼úº°

  • ºÀÇÕ°ú À̽Ä
  • À̽Ä
  • À¯¸® Á¶Á÷ À̽Ä
  • ±âŸ ÀýÂ÷

Á¦7Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¼­Àú¸® ½ÃÀå : ¿ëµµº°

  • ½Å°æ ¸¶ÀÌÅ©·Î¼­Àú¸®
  • Ä¡°ú ¸¶ÀÌÅ©·Î¼­Àú¸®
  • ¾È°ú ¸¶ÀÌÅ©·Î¼­Àú¸®
  • ºÎÀΰú ¹× ºñ´¢±â°ú ¸¶ÀÌÅ©·Î¼­Àú¸®
  • À̺ñÀÎÈİú(ENT)
  • Á¤Çü¿Ü°ú ¸¶ÀÌÅ©·Î¼­Àú¸®
  • Çü¼º ¹× Àç°Ç¿ë ¸¶ÀÌÅ©·Î¼­Àú¸®
  • ±âŸ ¿ëµµ

Á¦8Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¼­Àú¸® ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø
  • Çмú ¿¬±¸ ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ¼¼°èÀÇ ¸¶ÀÌÅ©·Î¼­Àú¸® ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦11Àå ±â¾÷ °³¿ä

  • Scanlan International
  • Olympus Corp.
  • HAAG-STREIT GROUP
  • Accurate Surgical & Scientific Instruments Corp.
  • Surtex Instruments Ltd.
  • KLS Martin Group
  • Topcon Corp.
  • Integra LifeSciences
  • B. Braun Melsungen Inc.
  • Leica Microsystems
  • Carl Zeiss AG
  • Medtronic
  • Novartis AG
  • Baxter
  • Halma PLC
  • Peter LAZIC GmbH
  • Danaher
  • SYNOVIS MICRO COMPANIES ALLIANCE
  • AROSurgical Instruments
ksm 24.02.20

According to Stratistics MRC, the Global Microsurgery Market is accounted for $2.24 billion in 2023 and is expected to reach $3.65 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Microsurgery is a highly specialized surgical procedure that uses delicate sutures, magnifying equipment such as microscopes, and precise instruments to operate on minuscule bodily components. Surgeons may carry out complex operations on fragile tissues, blood vessels, nerves, and other microscopic anatomical features that are sometimes invisible to the unaided eye. Moreover, the precise nature of microsurgery techniques needs particular training and abilities for surgeons conducting them. Techniques include precision suturing using ultra-fine needles and sutures, careful attention to detail, and sensitive tissue manipulation.

According to a research study published by the National Library of Medicine in June 2021, under magnification, the microsurgical method for root coverage was found to be superior to the traditional microsurgical approach, and in addition to enhanced gingival thickness and patient satisfaction ratings, neovascularization at the microsurgical sites healed more quickly.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

Chronic diseases such as cardiovascular disorders, diabetes, cancer, and neurological conditions often necessitate complex and precise surgical interventions. Microsurgery plays a crucial role in treating these conditions. Minimally invasive surgeries, facilitated by microsurgical techniques and instruments, offer reduced trauma, quicker recovery times, and improved patient outcomes. The market for microsurgery benefits from this trend as it aligns with the increasing preference for less invasive approaches among patients and surgeons.

Restraint:

Integrating new microsurgical technologies into existing healthcare systems

Incorporating new microsurgical technologies into existing healthcare systems requires significant planning and execution. It involves integrating these technologies with the current infrastructure, including operating rooms, electronic health records (EHR) systems, and other surgical equipment. This complexity can lead to delays and additional expenses during the implementation phase. Moreover, compatibility issues between different technologies or software platforms may arise, leading to inefficiencies and data management challenges hamper the growth of the market.

Opportunity:

Growing technological advances in surgical procedures

Technological developments have greatly enhanced precision and visibility during microsurgical procedures, especially with regard to operating microscopes, imaging modalities, and instruments. Continuous developments in the field of materials science have resulted in the creation of specific tools and materials that enhance surgical results. Microsurgical instruments composed of modern alloys or composite materials, for example, have improved biocompatibility, endurance, and accuracy, all of which boost their effectiveness during treatments.

Threat:

High cost

The significant expenses related to specialized microsurgical equipment, instruments, and training can limit accessibility to microsurgery. Smaller healthcare facilities, especially in resource-constrained regions or developing countries, may struggle to afford the initial investment and ongoing costs, leading to limited availability of microsurgical services in these areas. This strain may limit the allocation of funds for the development of microsurgical departments or investment in cutting-edge technologies, impacting overall healthcare quality.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the microsurgery market, causing disruptions across various fronts. Elective microsurgical procedures experienced a substantial decline as healthcare facilities prioritized resources for pandemic response, leading to postponed surgeries and reduced patient volumes. Supply chain disruptions affected the availability of specialized microsurgical instruments and operating microscopes due to manufacturing constraints and logistical challenges. Stringent safety protocols and increased utilization of personal protective equipment (PPE) during surgeries became imperative, influencing procedural workflows.

The operating microscopes segment is expected to be the largest during the forecast period

Operating microscopes used in microsurgery are expected to have a lucrative growth due to characteristics such as enhanced optics, high-resolution cameras, and illumination systems that provide magnification and increased vision. They give doctors clear, thorough views of the surgical site, enabling them to perform precise, systematic procedures. These microscopes are used in a wide range of medical specialties, such as gynecology, urology, neurology, ophthalmology, plastic surgery, orthopedics, and ENT. This promotes market expansion.

The neurological microsurgeries segment is expected to have the highest CAGR during the forecast period

The neurological microsurgeries segment is anticipated to witness the highest CAGR growth during the forecast period, as a broad variety of operations affecting the brain, spinal cord, nerves, and surrounding tissues are included in the field of neurological microsurgery. For these operations, high-quality operating microscopes with sophisticated optics, strong magnification, and lighting capabilities are crucial for seeing and working with small neurological structures. These microscopes improve sight for neurosurgeons, allowing them to precisely execute complex surgery.

Region with largest share:

North America is projected to hold the largest market share during the forecast period because of its highly developed healthcare system, high incidence of infectious illnesses, numerous big national clinical labs, and convenient access to cutting-edge technology. Moreover due to the increased demand for infectious disease diagnostic kits brought on by an expanding patient pool and growing public awareness and approval from regulatory bodies for the use of surgical microscopes by surgeons is also responsible for driving the market's growth in the region.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the surge is attributed to an increase in the senior population, who are more likely to experience issues related to chronic illnesses. Due to the lack of innovation from the industry's major players, new, independent businesses have entered the market and are offering high-quality, reasonably priced items thus rising disposable income, and expanding access to healthcare encourage the growth of the market

Key players in the market

Some of the key players profiled in the Microsurgery Market include Scanlan International, Olympus Corp., HAAG-STREIT GROUP, Accurate Surgical & Scientific Instruments Corp., Surtex Instruments Ltd., KLS Martin Group, Topcon Corp., Integra LifeSciences, B. Braun Melsungen Inc., Leica Microsystems, Carl Zeiss AG, Medtronic, Novartis AG, Baxter, Halma PLC, Peter LAZIC GmbH, Danaher, SYNOVIS MICRO COMPANIES ALLIANCE and AROSurgical Instruments

Key Developments:

In December 2023, Integra LifeSciences Announces Definitive Agreement To Acquire Acclarent®. The acquisition will become part of Integra's Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the neurosurgery segment.

In November 2023, Medtronic announces FDA approval of minimally invasive device to treat hypertension. With this approval, Medtronic will immediately begin commercialization.

In May 2023, Medtronic to acquire wearable insulin patch maker EOFlow, this acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support.

Product Types Covered:

  • Operating Microscopes
  • Microsurgery Needle Holder
  • Micro Forceps
  • Micro Sutures
  • Other Product Types

Procedures Covered:

  • Suture and Grafting
  • Transplantation
  • Free Tissue Transfer
  • Other Procedures

Applications Covered:

  • Neurological Microsurgeries
  • Dental Microsurgeries
  • Ophthalmic Microsurgeries
  • Gynecological & Urological Microsurgeries
  • Ear Nose Throat (ENT)
  • Orthopedic Microsurgeries
  • Plastic & Reconstructive Microsurgeries
  • Other Applications

End Users Covered:

  • Ambulatory Surgery Centers
  • Hospitals
  • Academic & Research Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Microsurgery Market, By Product Type

  • 5.1 Introduction
  • 5.2 Operating Microscopes
  • 5.3 Microsurgery Needle Holder
  • 5.4 Micro Forceps
  • 5.5 Micro Sutures
  • 5.6 Other Product Types

6 Global Microsurgery Market, By Procedure

  • 6.1 Introduction
  • 6.2 Suture and Grafting
  • 6.3 Transplantation
  • 6.4 Free Tissue Transfer
  • 6.5 Other Procedures

7 Global Microsurgery Market, By Application

  • 7.1 Introduction
  • 7.2 Neurological Microsurgeries
  • 7.3 Dental Microsurgeries
  • 7.4 Ophthalmic Microsurgeries
  • 7.5 Gynecological & Urological Microsurgeries
  • 7.6 Ear Nose Throat (ENT)
  • 7.7 Orthopedic Microsurgeries
  • 7.8 Plastic & Reconstructive Microsurgeries
  • 7.9 Other Applications

8 Global Microsurgery Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgery Centers
  • 8.3 Hospitals
  • 8.4 Academic & Research Centers
  • 8.5 Other End Users

9 Global Microsurgery Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Scanlan International
  • 11.2 Olympus Corp.
  • 11.3 HAAG-STREIT GROUP
  • 11.4 Accurate Surgical & Scientific Instruments Corp.
  • 11.5 Surtex Instruments Ltd.
  • 11.6 KLS Martin Group
  • 11.7 Topcon Corp.
  • 11.8 Integra LifeSciences
  • 11.9 B. Braun Melsungen Inc.
  • 11.10 Leica Microsystems
  • 11.11 Carl Zeiss AG
  • 11.12 Medtronic
  • 11.13 Novartis AG
  • 11.14 Baxter
  • 11.15 Halma PLC
  • 11.16 Peter LAZIC GmbH
  • 11.17 Danaher
  • 11.18 SYNOVIS MICRO COMPANIES ALLIANCE
  • 11.19 AROSurgical Instruments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦